Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
Future Oncol ; 18(3): 333-348, 2022 Jan.
Article in English | MEDLINE | ID: mdl-34756116

ABSTRACT

Background: Papillary thyroid carcinoma (PTC) is one of the most common endocrine malignancies and has a favorable prognosis. However, optimal treatments and prognostic markers have not been clearly identified. Methods: Gene expression data from primary PTC were downloaded from the Gene Expression Omnibus database and subjected to two analyses of differentially expressed genes (DEGs), followed by intersecting individual and integrated DEGs analyses as well as gene set enrichment analysis. Analysis of data from Sequence Read Archive and The Cancer Genome Atlas, immunohistochemistry and qRT-PCR of TFF3 were performed to validate the results. Finally, the relationship between gene expression and disease-free survival as well as immune cell infiltration were investigated. Results: Six critical DEGs and several tumor-enriched signaling pathways were identified. Immunohistochemistry and qRT-PCR validated the low expression of TFF3 in PTC. TFF3 and FCGBP are coexpressed in PTC, and patients with lower gene expression had worse disease-free survival but higher immune cell infiltration. Conclusion: TFF3 was significantly underexpressed and may function with FCGBP synergistically in PTC.


Lay abstract Thyroid cancers are some of the most common endocrine malignancies. However, the optimal treatments and prognostic markers have not been clearly identified. We identified six critical differentially expressed genes and several tumor-enriched signaling pathways in papillary thyroid carcinoma, and found that TFF3 was the most underexpressed gene, as validated by experiment. In addition, TFF3 and FCGBP worked synergistically and may mark prognosis and tumor immune cell infiltration, which may benefit patients with papillary thyroid carcinoma by providing early indication and prompting further basic investigation.


Subject(s)
Biomarkers, Tumor/genetics , Neoplasm Recurrence, Local/epidemiology , Thyroid Cancer, Papillary/mortality , Thyroid Neoplasms/mortality , Trefoil Factor-3/genetics , Adult , Biomarkers, Tumor/analysis , Cell Adhesion Molecules/analysis , Cell Adhesion Molecules/genetics , Datasets as Topic , Disease-Free Survival , Female , Follow-Up Studies , Gene Expression Profiling , Gene Expression Regulation, Neoplastic/immunology , Humans , Immunohistochemistry , Male , Middle Aged , Neoplasm Recurrence, Local/genetics , Risk Assessment/methods , Thyroid Cancer, Papillary/genetics , Thyroid Cancer, Papillary/immunology , Thyroid Cancer, Papillary/surgery , Thyroid Gland/immunology , Thyroid Gland/pathology , Thyroid Gland/surgery , Thyroid Neoplasms/genetics , Thyroid Neoplasms/immunology , Thyroid Neoplasms/surgery , Thyroidectomy , Trefoil Factor-3/analysis , Tumor Microenvironment/immunology
2.
Oncol Rep ; 45(1): 254-264, 2021 01.
Article in English | MEDLINE | ID: mdl-33210724

ABSTRACT

In colorectal cancer (CRC), high expression of trefoil factor 3 (TFF3) is associated with tumor progression and reduced patient survival; however, bioinformatics analyses of public 'omics' databases show low TFF3 expression in CRCs as compared to normal tissues. Thus, we examined TFF3 expression in CRCs and matching normal tissues to evaluate its role in CRC progression. TFF3 gene expression was characterized using the bioinformatics portal UALCAN (http://ualcan.path.uab.edu). Tissue microarrays (TMAs) of archival CRC specimens (n=96) were immunostained with anti­human TFF3 antibodies. Immunohistochemical (IHC) staining intensity was semi­quantitatively scored. For this cohort, the median follow­up was 5.4 years. Associations between clinical and pathological variables were determined using Chi­square or Fisher's exact tests. Univariate disease­free survival was estimated by the Kaplan­Meier method. Omics data analyses by UALCAN showed downregulation of TFF3 expression in CRC relative to normal tissue at protein (χ2, P<0.0001) levels. There was a similar decreasing trend of TFF3 expression in the pathologic stages of the CRCs (RNA, χ2, P=0.88 and protein, χ2 P<0.0001). UALCAN data analysis showed that TFF3 exhibited 27% lower mRNA expression in tumors with mutant TP53 (P=0.007). Confirming the findings of omics analyses, IHC analysis of TMAs exhibited lower TFF3 expression in 95.6% (65 of 68) of the available normal­tumor matching pairs (χ2, P<0.0001). There was no statistically significant association of tumor TFF3 expression with patient sex, race/ethnicity, tumor location within the colorectum, Tumor, Node, Metastasis (TNM) stage, lymph node metastasis, or surgical margins. However, low TFF3 IHC staining in tumor tissue was associated with histological grade (P=0.026). Kaplan­Meier survival analysis showed no prognostic value of low TFF3 expression relative to those with high expression (log­rank, P=0.605). Our findings demonstrate low expression of TFF3 in CRCs. Association between low TFF3 and histopathological features suggests involvement of this molecule in progression of CRC.


Subject(s)
Colorectal Neoplasms/chemistry , Trefoil Factor-3/analysis , Adult , Aged , Aged, 80 and over , Colorectal Neoplasms/mortality , Colorectal Neoplasms/pathology , Computational Biology , Female , Humans , Male , Middle Aged , Mutation , Trefoil Factor-3/genetics , Tumor Suppressor Protein p53/analysis , Tumor Suppressor Protein p53/genetics
4.
J Clin Pathol ; 72(12): 825-829, 2019 Dec.
Article in English | MEDLINE | ID: mdl-31235543

ABSTRACT

AIMS: Aim was to assess the feasibility of serum markers to identify individuals at risk for gastro-oesophageal adenocarcinoma to reduce the number of individuals requiring invasive assessment by endoscopy. METHODS: Blood samples from 56 patients with Barrett's oesophagus and 202 non-Barrett controls who previously took part in a trial assessing the accuracy of the Cytosponge for Barrett's oesophagus were assessed for serum pepsinogen (PG) 1 and 2, gastrin-17, trefoil factor 3 (TFF3) and Helicobacter pylori infection. RESULTS: PG1 was pathological (<50 ng/mL) in 26 patients (10.1%), none of whom had Barrett's oesophagus (p<0.001). Smoking and drinking had no influence on these results. Pathological PG1 was associated with stomach pain (p=0.029), disruption of sleep (p=0.027) and disruption of diet by symptoms (p=0.019). Serum TFF3 was not associated with any clinical parameter. CONCLUSIONS: Assessment of serum PG1 could be combined with a test for Barrett's oesophagus to identify additional patients requiring endoscopy.


Subject(s)
Adenocarcinoma/blood , Barrett Esophagus/blood , Biomarkers, Tumor/blood , Early Detection of Cancer/methods , Esophageal Neoplasms/blood , Serologic Tests , Specimen Handling , Stomach Neoplasms/blood , Adenocarcinoma/epidemiology , Adenocarcinoma/pathology , Adult , Aged , Aged, 80 and over , Barrett Esophagus/epidemiology , Barrett Esophagus/pathology , Case-Control Studies , Early Detection of Cancer/instrumentation , Esophageal Neoplasms/epidemiology , Esophageal Neoplasms/pathology , Feasibility Studies , Female , Humans , Male , Middle Aged , Pepsinogen A/blood , Pepsinogen C/blood , Predictive Value of Tests , Prognosis , Reproducibility of Results , Risk Assessment , Risk Factors , Specimen Handling/instrumentation , Stomach Neoplasms/epidemiology , Stomach Neoplasms/pathology , Trefoil Factor-3/analysis , Young Adult
5.
Benef Microbes ; 9(3): 345-355, 2018 Apr 25.
Article in English | MEDLINE | ID: mdl-29633639

ABSTRACT

Previously we showed that urine trefoil factor 3 (TFF3) levels were higher in females with irritable bowel syndrome (IBS) compared to non-IBS females. To assess if TFF3 is associated with symptoms and/or reflect alterations in gastrointestinal permeability and gut microbiota in an IBS population, we correlated stool and urine TFF3 levels with IBS symptoms, intestinal permeability, stool microbial diversity and relative abundance of predominant bacterial families and genera. We also tested the relationship of stool TFF3 to urine TFF3, and compared results based on hormone contraception use. Samples were obtained from 93 females meeting Rome III IBS criteria and completing 4-week symptom diaries. TFF3 levels were measured by ELISA. Permeability was assessed with the urine lactulose/mannitol (L/M) ratio. Stool microbiota was assessed using 16S rRNA. Stool TFF3, but not urine TFF3, was associated positively with diarrhoea and loose stool consistency. Higher stool TFF3 was also associated with lower L/M ratio and microbial diversity. Of the 20 most abundant bacterial families Mogibacteriaceae and Christensenellaceae were inversely related to stool TFF3, with only Christensenellaceae remaining significant after multiple comparison adjustment. There were no significant relationships between stool or urine TFF3 levels and other symptoms, nor between stool and urine levels. In premenopausal females, urine TFF3 levels were higher in those reporting hormone contraception. Collectively these results suggest that higher stool TFF3 levels are associated with IBS symptoms (loose/diarrhoeal stools), lower gut permeability, and altered stool bacteria composition (decreased diversity and decreased Christensenellaceae), which further suggests that TFF3 may be an important marker of host-bacteria interaction.


Subject(s)
Feces/chemistry , Gastrointestinal Microbiome , Irritable Bowel Syndrome/pathology , Microbiota , Permeability , Trefoil Factor-3/analysis , Urine/chemistry , Adult , Aged , DNA, Bacterial/chemistry , DNA, Bacterial/genetics , DNA, Ribosomal/chemistry , DNA, Ribosomal/genetics , Enzyme-Linked Immunosorbent Assay , Female , Humans , Middle Aged , Phylogeny , RNA, Ribosomal, 16S/genetics , Sequence Analysis, DNA , Young Adult
6.
Eur J Surg Oncol ; 43(7): 1148-1160, 2017 Jul.
Article in English | MEDLINE | ID: mdl-28256346

ABSTRACT

Barrett's oesophagus is a condition which predisposes towards development of oesophageal adenocarcinoma, a highly lethal tumour which has been increasing in incidence in the Western world over the past three decades. There have been tremendous advances in the field of Barrett's oesophagus, not only in diagnostic modalities, but also in therapeutic strategies available to treat this premalignant disease. In this review, we discuss the past, present and future of Barrett's oesophagus. We describe the historical and new evolving diagnostic criteria of Barrett's oesophagus, while also comparing and contrasting the British Society of Gastroenterology guidelines, American College of Gastroenterology guidelines and International Benign Barrett's and CAncer Taskforce (BOBCAT) for Barrett's oesophagus. Advances in endoscopic modalities such as confocal and volumetric laser endomicroscopy, and a non-endoscopic sampling device, the Cytosponge, are described which could aid in identification of Barrett's oesophagus. With regards to therapy we review the evidence for the utility of endoscopic mucosal resection and radiofrequency ablation when coupled with better characterization of dysplasia. These endoscopic advances have transformed the management of Barrett's oesophagus from a primarily surgical disease into an endoscopically managed condition.


Subject(s)
Barrett Esophagus/diagnosis , Barrett Esophagus/therapy , Esophageal Neoplasms/prevention & control , Esophagoscopy/methods , Precancerous Conditions/diagnosis , Precancerous Conditions/therapy , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Barrett Esophagus/pathology , Catheter Ablation , Cryosurgery , Cytological Techniques/instrumentation , Endoscopic Mucosal Resection , Esophageal Neoplasms/etiology , Esophagectomy , Humans , Microscopy, Confocal , Practice Guidelines as Topic , Precancerous Conditions/pathology , Proton Pump Inhibitors/therapeutic use , Trefoil Factor-3/analysis , Watchful Waiting
7.
Acta Obstet Gynecol Scand ; 96(1): 47-52, 2017 Jan.
Article in English | MEDLINE | ID: mdl-27731893

ABSTRACT

INTRODUCTION: The viscoelastic properties of the cervical mucus plug are considered essential for the occlusion of the cervical canal and thereby for protection against ascending infections during pregnancy. Factors controlling this property are virtually unknown. This study explores a possible role of trefoil factor peptides 1, 2 and 3 (TFF1-3); peptides believed to influence mucus viscosity. MATERIAL AND METHODS: The study is based on spontaneously shed cervical mucus plugs from 14 women in active labor. The viscoelastic properties; the elastic modulus (G') and the viscous modulus (G") were determined by an oscillatory rheometer. The concentrations of TFF1-3 were measured by an in-house enzyme-linked immunosorbent assay. Associations were analyzed by random-effects generalized least-squares regression analyses. RESULTS: Median (range) concentrations of TFF1, TFF2 and TFF3 were 3.1 (1.2-8.6), 1.1 (<0.006-3.7) and 1000 (170-5300) nmol/g cervical mucus plug, respectively. The TFF3 concentration was associated with G' (regression coefficient 11.7 Pa/Log nm; 95% CI 3.0-20.4, p = 0.009) and G" (regression coefficient 3.2 Pa/Log nm; 95% CI 1.5-5.0, p < 0.001). CONCLUSION: We suggest that TFF3 plays a role in the viscoelastic properties of the cervical mucus plug.


Subject(s)
Cervix Mucus/chemistry , Elastic Modulus , Trefoil Factor-3/analysis , Viscosity , Adult , Enzyme-Linked Immunosorbent Assay , Female , Humans , Least-Squares Analysis , Pregnancy , Young Adult
8.
Cytokine ; 86: 10-14, 2016 10.
Article in English | MEDLINE | ID: mdl-27442005

ABSTRACT

Influenza A viruses (IAV) mutate rapidly and cause seasonal epidemics and occasional pandemics, which result in substantial number of patient visits to the doctors and even hospitalizations. We aimed here to identify inflammatory proteins, which levels correlated to clinical severity of the disease. For this we analysed 102 cytokines and growth factors in human nasopharyngeal aspirate (NPA) samples of 27 hospitalized and 27 outpatients diagnosed with influenza A(H1N1)pdm09 virus infection. We found that the relative levels of monocyte differentiation antigen CD14, lipocalin-2 (LCN2), C-C-motif chemokine 20 (CCL20), CD147, urokinase plasminogen activator surface receptor (uPAR), pro-epidermal growth factor (EGF), trefoil factor 3 (TFF3), and macrophage migration inhibitory factor (MIF) were significantly lower (p<0.008), whereas levels of retinol-binding protein 4 (RBP4), C-X-C motif chemokine 5 (CXCL5), interleukin-8 (IL-8), complement factor D (CFD), adiponectin, and chitinase-3-like 1 (CHI3L1) were significantly higher (p<0.008) in NPA samples of hospitalized than non-hospitalized patients. While changes in CD14, LCN2, CCL20, uPAR, EGF, MIF, CXCL5, IL-8, adiponectin and CHI3L1 levels have already been correlated with severity of IAV infection in mice and humans, our study is the first to describe association of CD147, RBP4, TFF3, and CFD with hospitalization of IAV-infected patients. Thus, we identified local innate immune profiles, which were associated with the clinical severity of influenza infections.


Subject(s)
Chemokines/analysis , Cytokines/analysis , Influenza A Virus, H1N1 Subtype/immunology , Influenza, Human/immunology , Influenza, Human/virology , Nasopharynx/immunology , Adult , Basigin/analysis , Female , Hospitalization , Humans , Immunity, Innate , Influenza, Human/diagnosis , Influenza, Human/epidemiology , Male , Middle Aged , Nasopharynx/virology , Outpatients , Pilot Projects , Protein Array Analysis , Retinol-Binding Proteins, Plasma/analysis , Severity of Illness Index , Trefoil Factor-3/analysis
SELECTION OF CITATIONS
SEARCH DETAIL
...